Publication:
Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?

Loading...
Thumbnail Image

Date

2017-01-03

Authors

Rivero-Juarez, Antonio
Frias, Mario
Lopez-Lopez, Pedro
de Los Angeles Risalde, María
Brieva, Teresa
Machuca, Isabel
Camacho, Angela
Martinez-Peinado, Antonio
Gomez-Villamandos, Jose Carlos
Rivero, Antonio

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

OXFORD ACADEMIC
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Although hepatitis E virus (HEV) is regarded as a self-limiting infection and anti-HEV antibodies seem to protect against reinfection, its pathogenesis is not well established. We describe 2 cases of acute symptomatic HEV infection after hepatitis C therapy in patients carrying anti-HEV immunoglobulin G antibodies, raising 2 major questions: reactivation or reinfection?

Description

MeSH Terms

Aged
Antiretroviral Therapy, Highly Active
Antiviral Agents
Coinfection
Female
HIV Infections
Hepatitis Antibodies
Hepatitis C
Hepatitis E
Hepatitis E virus
Humans
Immunoglobulin G
Immunoglobulin M
Male
Middle Aged
Viral Load
Virus Activation

DeCS Terms

Activacion Viral
Anciano
Anticuerpos antihepatitis
Antivirales
Carga Viral
Coinfeccion
Femenino
Humanos
Infecciones por VIH

CIE Terms

Keywords

HIV, Hepatitis C, Hepatitis E, Reactivation, Reinfection

Citation

Rivero-Juarez A, Frias M, Lopez-Lopez P, de Los Angeles Risalde M, Brieva T, Machuca I, et al. Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection? Clin Infect Dis. 2017 Apr 1;64(7):964-966